San Francisco, CA. January 30, 2023 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced its...
Vial Partners with RecensMedical in Phase III Clinical Trial to Further Ophthalmology Innovations
San Francisco, CA. January 25, 2023 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, has partnered...
Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018-205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
San Francisco, CA. January 19, 2023 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced that the first patient has...
Vial Welcomes Dr. Stewart Tepper of the Geisel School of Medicine at Dartmouth College to their Central Nervous System Scientific Advisory Board.
San Francisco, CA. January 16, 2023 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Stewart J. Tepper,...
Vial Announces New Central Nervous System Scientific Advisory Board Member, Dr. Jacqueline French of the Epilepsy Study Consortium and NYU Grossman School of Medicine.
San Francisco, CA. January 12, 2023 — Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition...
Vial Announces the Addition of Dr. Christopher Sweeney of SAiGENCI and the University of Adelaide to their Oncology CRO Scientific Advisory Board
San Francisco, CA. December 19, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Christopher Sweeney,...
Dr. Peter Goadsby of the NIHR Wellcome Trust at the King’s College Clinical Research Facility, London, Joins Vial’s Neurology CRO as a Scientific Advisor
San Francisco, CA. December 14, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, welcomes Dr. Peter Goadsby as a...
Vial Announces the Addition of Dr. Veeral Sheth of the University Retina and Macula Associates and the University of Illinois, Chicago, to their Ophthalmology CRO Scientific Advisory Board
San Francisco, CA. December 13, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Veeral Sheth,...
Vial Announces the Addition of Dr. Michael W. Lawlor of the Medical College of Wisconsin and the Diverge Translational Science Laboratory to their Central Nervous System Scientific Advisory Board
San Francisco, CA. December 6, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Michael W....
